Eversept Partners, LP: 13F holdings
CIK 16970132026Q2
| Positions | 119 |
|---|
| Reported value | $1.9bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 119 (+2 vs prior quarter) |
|---|
| Reported value | $1.9bn (+1.6%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| UTHR UNITED THERAPEUTICS CORP DEL | 287,668 | $155.9m | 8.1% |
| ABVX ABIVAX SA | 913,880 | $121.8m | 6.3% |
| EHC ENCOMPASS HEALTH CORP | 1,026,919 | $103.8m | 5.4% |
| ENSG ENSIGN GROUP INC | 602,079 | $96.5m | 5.0% |
| VERA VERA THERAPEUTICS INC | 2,212,770 | $94.9m | 4.9% |
| CLDX CELLDEX THERAPEUTICS INC NEW | 1,785,941 | $66.5m | 3.4% |
| SNDX SYNDAX PHARMACEUTICALS INC | 2,798,210 | $61.2m | 3.2% |
| BKD BROOKDALE SR LIVING INC | 3,396,470 | $54.6m | 2.8% |
| IONS IONIS PHARMACEUTICALS INC | 664,684 | $52.7m | 2.7% |
| NTRA NATERA INC | 175,807 | $47.7m | 2.5% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1697013")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples